InvestorsHub Logo
Followers 1173
Posts 171334
Boards Moderated 4
Alias Born 12/20/2003

Re: 02opida post# 616459

Sunday, 04/07/2024 7:58:41 AM

Sunday, April 07, 2024 7:58:41 AM

Post# of 620960
BMY - Bristol Myers Squibb Presents New Interim Long-Term Efficacy Data from the EMERGENT-4 Trial Evaluating KarXT in Schizophrenia at the 2024 Annual Congress of the Schizophrenia International Research Society
[2024-04-06 13:15]

History.htm

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.